AVITA Medical, Inc. (RCEL) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	75.6M	71.6M	64.3M	50.1M	34.4M
Cost of Revenue	13.9M	12.8M	9.1M	7.8M	6.0M
Gross Profit	61.7M	58.8M	55.2M	42.4M	28.4M
Operating Expenses
R&D Expense	20.1M	20.8M	20.4M	20.8M	13.9M
SG&A Expense	76.8M	80.5M	91.4M	65.6M	45.2M
General & Admin Expense	26.3M	27.4M	33.2M	28.3M	23.3M
Selling & Marketing Expense	50.4M	53.1M	58.2M	37.3M	21.9M
Other Expenses	—	—	—	(1.4M)	(3.2M)
Total Operating Expenses	96.9M	101.3M	111.8M	85.0M	55.9M
Cost and Expenses	110.8M	114.1M	120.8M	92.8M	61.9M
Operating Income (EBIT)	(35.2M)	(42.5M)	(56.6M)	(42.7M)	(27.5M)
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	5.4M	5.0M	5.4M	1.1M	16.0K
Net Interest Income	(5.4M)	(5.0M)	(5.4M)	(1.1M)	(16.0K)
Other Non-Op Income/Expense	(7.8M)	(6.0M)	(5.2M)	7.3M	876.0K
Non-Operating Income (excl Interest)	2.4M	1.0M	(163.0K)	(8.5M)	(892.0K)
EBT (Pre-Tax Income)	(43.1M)	(48.6M)	(61.8M)	(35.3M)	(26.6M)
Income Tax Expense	20.0K	11.0K	54.0K	66.0K	36.0K
Bottom Line
Net Income	(43.1M)	(48.6M)	(61.8M)	(35.4M)	(26.7M)
Earnings from Cont. Ops	(43.1M)	(48.6M)	(61.8M)	(35.4M)	(26.7M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(43.1M)	(48.6M)	(61.8M)	(35.4M)	(26.7M)
Per Share
Basic EPS	($1.45)	($1.74)	($2.39)	($1.40)	($1.07)
Diluted EPS	($1.45)	($1.74)	($2.39)	($1.40)	($1.07)
Revenue Per Share	$2.46	$2.57	$2.48	$1.98	$1.38
Shares
Basic Shares Outstanding	30.7M	27.9M	25.9M	25.3M	25.0M
Diluted Shares Outstanding	30.7M	27.9M	25.9M	25.3M	25.0M
Profitability Metrics
EBITDA	(34.4M)	(41.2M)	(55.3M)	(33.5M)	(26.0M)
D&A	3.3M	2.3M	1.1M	632.0K	568.0K
EBIT	(37.7M)	(43.6M)	(56.4M)	(34.2M)	(26.6M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026